First Manhattan’s iShares Biotechnology ETF IBB Stock Holding History

First Manhattan’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,911	Closed	-$323K	–	771
2026 Q1	$323K	Hold	1,911	–	–	﹤0.01%	651
2025 Q4	$323K	Hold	1,911	–	–	﹤0.01%	632
2025 Q3	$276K	Sell	1,911 -31	-2%	-$4.23K	﹤0.01%	637
2025 Q2	$246K	Sell	1,942 -4	-0.2%	-$491	﹤0.01%	649
2025 Q1	$249K	Sell	1,946 -498	-20%	-$67.5K	﹤0.01%	616
2024 Q4	$323K	Buy	+2,444	New	+$344K	﹤0.01%	588
2024 Q2	–	Sell	-540	Closed	-$74.1K	–	948
2024 Q1	$74.1K	Hold	540	–	–	﹤0.01%	813
2023 Q4	$73.4K	Hold	540	–	–	﹤0.01%	799
2023 Q3	$66K	Hold	540	–	–	﹤0.01%	820
2023 Q2	$68.6K	Hold	540	–	–	﹤0.01%	830
2023 Q1	$69.7K	Hold	540	–	–	﹤0.01%	865
2022 Q4	$70.9K	Hold	540	–	–	﹤0.01%	881
2022 Q3	$63K	Sell	540 -600	-53%	-$74.5K	﹤0.01%	897
2022 Q2	$134K	Hold	1,140	–	–	﹤0.01%	786
2022 Q1	$148K	Buy	1,140 +540	+90%	+$70.3K	﹤0.01%	813
2021 Q4	$91K	Hold	600	–	–	﹤0.01%	889
2021 Q3	$97K	Hold	600	–	–	﹤0.01%	870
2021 Q2	$98K	Hold	600	–	–	﹤0.01%	865
2021 Q1	$90K	Sell	600 -375	-38%	-$59.6K	﹤0.01%	844
2020 Q4	$147K	Sell	975 -90	-8%	-$12.9K	﹤0.01%	725
2020 Q3	$144K	Buy	1,065 +375	+54%	+$50.9K	﹤0.01%	696
2020 Q2	$94K	Hold	690	–	–	﹤0.01%	780
2020 Q1	$74K	Buy	+690	New	+$79.4K	﹤0.01%	782
2019 Q3	–	Sell	-100	Closed	-$10K	–	1364
2019 Q2	$10K	Buy	+100	New	+$10.6K	﹤0.01%	1182
2017 Q1	–	Sell	-555	Closed	-$49K	–	1417
2016 Q4	$49K	Hold	555	–	–	﹤0.01%	926
2016 Q3	$53K	Hold	555	–	–	﹤0.01%	912
2016 Q2	$47K	Buy	+555	New	+$49.8K	﹤0.01%	961

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

First Manhattan's IBB Position: Q2 2026 in Review

First Manhattan sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 1,911 shares — an estimated $323K sold.

First Manhattan first reported a position in IBB in Q2 2016 and held it in 27 quarters. The position peaked at $323K in Q4 2024. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

First Manhattan reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
First Manhattan sold 1,911 iShares Biotechnology ETF shares in Q2 2026, an estimated $323K.
First Manhattan first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 27 quarters.
First Manhattan's iShares Biotechnology ETF position peaked at $323K in Q4 2024.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on First Manhattan's 13F filing for Q2 2026, filed 14 Aug 2026.